메뉴 건너뛰기
Chinese Medical Journal
Volumn 115, Issue 12, 2002, Pages 1814-1818
An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B
Author keywords

Chronic Hepatitis B; Hepatitis B 1virus; Lamivudine; YMDD mutation
Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTIC ACID; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; METHIONINE; PLACEBO; TYROSINE; VIRUS DNA;
EID: 0036958576     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)
References (8)
  • 1
    • 0032499913 scopus 로고    scopus 로고
    • A one year trial of lamivudine for chronic hepatitis B
    • Lai CL, Liaw YF, Leung NW, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68.
    • (1998) N. Engl. J. Med. , vol.339 , pp. 61-68
    • Lai, C.L.1    Liaw, Y.F.2    Leung, N.W.3
  • 2
    • 0033592764 scopus 로고    scopus 로고
    • Lamivudine as initial treatment for chronic hepatitis B in the United States
    • Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999:341:1256-1263.
    • (1999) N. Engl. J. Med. , vol.341 , pp. 1256-1263
    • Dienstag, J.L.1    Schiff, E.R.2    Wright, T.L.3
  • 3
    • 0032937012 scopus 로고    scopus 로고
    • A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection
    • Yao GB, Wang BE, Cui ZY. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection. Chin Med J 1999;112: 387-391.
    • (1999) Chin. Med. J. , vol.112 , pp. 387-391
    • Yao, G.B.1    Wang, B.E.2    Cui, Z.Y.3
  • 4
    • 0032849751 scopus 로고    scopus 로고
    • Two sensitive PCR-based methods for the detection of hepatitis B virus variants associated with reduced susceptibility in lamivudine
    • Allen M, Gauther J, Des Lauries M, et al. Two sensitive PCR-based methods for the detection of hepatitis B virus variants associated with reduced susceptibility in lamivudine. J Clin Microbiol 1999;37:3338-3347.
    • (1999) J. Clin. Microbiol. , vol.37 , pp. 3338-3347
    • Allen, M.1    Gauther, J.2    Des Lauries, M.3
  • 5
    • 0034235528 scopus 로고    scopus 로고
    • Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
    • Liaw YF, Leung NWY, Chang TT, et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology 2000;119:172-180.
    • (2000) Gastroenterology , vol.119 , pp. 172-180
    • Liaw, Y.F.1    Leung, N.W.Y.2    Chang, T.T.3
  • 6
    • 0034993211 scopus 로고    scopus 로고
    • Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy
    • Leung NWY, Lai CL, Chang TT, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 2001;33:1527-1532.
    • (2001) Hepatology , vol.33 , pp. 1527-1532
    • Leung, N.W.Y.1    Lai, C.L.2    Chang, T.T.3
  • 7
    • 0033144743 scopus 로고    scopus 로고
    • Long-term efficacy of lamivudine in the treatment of hepatitis B patients
    • Yao GB, Wang BE, Cui ZY. Long-term efficacy of lamivudine in the treatment of hepatitis B patients. Chin J Hepatol 1999;7:80-83.
    • (1999) Chin. J. Hepatol. , vol.7 , pp. 80-83
    • Yao, G.B.1    Wang, B.E.2    Cui, Z.Y.3
  • 8
    • 0000628979 scopus 로고    scopus 로고
    • YMDD mutation in Chinese patients following lamivudine therapy for chronic hepatitis B infection
    • Yao GB. YMDD mutation in Chinese patients following lamivudine therapy for chronic hepatitis B infection. Gastroenterology 1999;116:A848-A849.
    • (1999) Gastroenterology , vol.116
    • Yao, G.B.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.